Form 4: Sera Prognostics Director Wilson Receives Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Marcus Dean Wilson acquired stock options and restricted stock units in Sera Prognostics, Inc.

Summary

  • On July 13, 2024, Marcus Dean Wilson, a director of Sera Prognostics, Inc., acquired 7,117 shares of Class A Common Stock in the form of restricted stock units (RSUs).
  • These RSUs vest monthly over one year, starting June 6, 2024, contingent on continued service to the issuer.
  • Wilson also acquired 10,549 stock options with an exercise price of $8.43, vesting monthly over one year from June 6, 2024, also contingent on continued service.
  • Following these transactions, Wilson directly owns 7,117 shares of Class A Common Stock and 10,549 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard compensation practices and aligns director interests with shareholders. There are no red flags or negative implications.

Positives

  • The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
  • The vesting schedule incentivizes continued service and contribution to the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule implies an expectation of continued service from the director.

Industry Context

Granting stock options and RSUs to directors is a common practice to align their interests with those of the shareholders and incentivize long-term value creation. This is typical compensation for board members in publicly traded companies.

Comparison to Industry Standards

  • Stock option and RSU grants are standard compensation practices for directors in publicly traded companies, particularly in the biotech and diagnostics sectors.
  • Companies like Myriad Genetics and Exact Sciences also utilize equity-based compensation to align director and shareholder interests.
  • The vesting schedule of one year is relatively standard, ensuring continued commitment from the director.

Stakeholder Impact

  • The grant of equity to a director can positively impact shareholders by aligning management's interests with theirs.
  • Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
June 6, 2024Vesting commencement date for RSUs and stock options.
July 13, 2024Date of transaction: acquisition of RSUs and stock options.
July 15, 2024Date of signature for the Form 4 filing.
July 13, 2034Expiration date for the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.